Literature DB >> 11243812

Papillomavirus capsid protein expression in Escherichia coli: purification and assembly of HPV11 and HPV16 L1.

X S Chen1, G Casini, S C Harrison, R L Garcea.   

Abstract

The L1 major capsid proteins of human papillomavirus (HPV) types 11 and 16 were purified and analyzed for structural integrity and in vitro self-assembly. Proteins were expressed in Escherichia coli as glutathione-S-transferase-L1 (GST-L1) fusions and purified to near homogeneity as pentamers (equivalent to viral capsomeres), after thrombin cleavage from the GST moiety and removal of tightly associated GroEL protein. Sequences at the amino and carboxy termini contributing to formation of L1 pentamers and to in vitro capsid assembly were identified by deletion analysis. For both HPV11 and HPV16 L1, up to at least ten residues could be deleted from the amino terminus (Delta N10) and 30 residues from the carboxy terminus (Delta C30) without affecting pentamer formation. The HPV16 pentamers assembled into relatively regular, 72-pentamer shells ("virus-like particles" or VLPs) at low pH, with the exception of HPV16 L1 Delta N10, which assembled into a 12-pentamer, T=1 capsid (small VLP) under all conditions tested. The production of large quantities of assembly-competent L1, using the expression and purification protocol described here, has been useful for crystallographic analysis, and will be valuable for studies of virus-receptor interactions and potentially for vaccine design. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11243812     DOI: 10.1006/jmbi.2000.4464

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  52 in total

1.  Development of bead-based immunoassay to quantify neutralizing antibody for human papillomavirus 16 and 18.

Authors:  Hai-Bo Liu; Pankaj Kumar Chaturvedi; Gantumur Battogtokh; Hyo Joo Bang; In-Wook Kim; Yong-Wan Kim; Kye-Shin Park; Woong Shick Ahn
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

2.  Atomic model of the papillomavirus capsid.

Authors:  Yorgo Modis; Benes L Trus; Stephen C Harrison
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

3.  Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection.

Authors:  Subhashini Jagu; Kihyuck Kwak; Robert L Garcea; Richard B S Roden
Journal:  Vaccine       Date:  2010-04-29       Impact factor: 3.641

Review 4.  Prevention of cancer by prophylactic human papillomavirus vaccines.

Authors:  Kihyuck Kwak; Anna Yemelyanova; Richard B S Roden
Journal:  Curr Opin Immunol       Date:  2010-12-23       Impact factor: 7.486

5.  Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

Authors:  Karina Araujo Aires; Aurora Marques Cianciarullo; Sylvia Mendes Carneiro; Luisa Lina Villa; Enrique Boccardo; Gaspar Pérez-Martinez; Isabel Perez-Arellano; Maria Leonor Sarno Oliveira; Paulo Lee Ho
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

6.  Purification, crystallization and structure determination of native GroEL from Escherichia coli lacking bound potassium ions.

Authors:  Philip D Kiser; David T Lodowski; Krzysztof Palczewski
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-05-05

Review 7.  Biological gene delivery vehicles: beyond viral vectors.

Authors:  Yiqi Seow; Matthew J Wood
Journal:  Mol Ther       Date:  2009-03-10       Impact factor: 11.454

8.  Branched-linear and agglomerate protein polymers as vaccine platforms.

Authors:  Leyi Wang; Ming Xia; Pengwei Huang; Hao Fang; Dianjun Cao; Xiang-Jin Meng; Monica McNeal; Xi Jiang; Ming Tan
Journal:  Biomaterials       Date:  2014-06-28       Impact factor: 12.479

9.  Virus-like particles and capsomeres are potent vaccines against cutaneous alpha HPVs.

Authors:  Tilo Senger; Lysann Schädlich; Sonja Textor; Corinna Klein; Kristina M Michael; Christopher B Buck; Lutz Gissmann
Journal:  Vaccine       Date:  2009-12-08       Impact factor: 3.641

Review 10.  Immunoprevention of human papillomavirus-associated malignancies.

Authors:  Joshua W Wang; Chein-Fu Hung; Warner K Huh; Cornelia L Trimble; Richard B S Roden
Journal:  Cancer Prev Res (Phila)       Date:  2014-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.